ALLIANCE
Aggressive Lipid Lowering Initiation Alleviates New Cardiovascular Endpoints

Purpose
To compare the effects of aggressive lipid lowering therapy with atorvastatin vs usual care in post-myocardial infarction patients

References
The trial design has not been published

Voltar

Apoio: Libbs Farmacêutica Farmacêutica